GLUCOSAFE 2.5 contains Glibenclamide which belongs to the group of medicines called Antidiabetic agents. It is used to treat type 2 diabetes mellitus, when diet and physical exercise alone have not been able to control the blood sugar levels.Type 2 diabetes is a disease in which blood sugar levels are too high and the body either doesn't produce enough insulin, or it resists insulin. Symptoms include increased thirst, hunger, urination, feeling tired, blurred vision, numbness or tingling in the feet or hands, sores that do not heal, weight loss.
Glibenclamide lowers blood sugar by helping the pancreas to produce insulin (natural substance needed to break down sugar in the body) so that the body can use insulin efficiently. This will only help lower blood sugar in bodies which produce insulin naturally. Along with this treatment, your doctor might ask you to make certain lifestyle changes such as eating a healthy diet, not skipping meals & regular exercise. Prior to the treatment, your doctor may want you to take several blood tests to understand your existing condition.
Avoid consumption of alcohol during treatment with GLUCOSAFE 2.5, as it may worsen the side effects. Before taking GLUCOSAFE 2.5, inform your doctor if you suffer from low blood sugar attack, have G6PD deficiency, recovering from an operation or stress. GLUCOSAFE 2.5 is not recommended for use in patients who have porphyria, insulin dependent diabetes, diabetic ketoacidosis, diabetic coma, serious problems with kidneys, liver, adrenal glands, or pituitary glands. GLUCOSAFE 2.5 is not recommended for use in pregnant and breastfeeding women. GLUCOSAFE 2.5 is also not recommended for use in children. Consult your doctor before taking it. The most common side effects of taking GLUCOSAFE 2.5 are low blood glucose levels characterized by dizziness, sweating, palpitations, hunger pangs, dry mouth and skin.
GLUCOSAFE 2.5 lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This will only help lower blood sugar in bodies which produce insulin naturally.
Take GLUCOSAFE 2.5 as advised by your physician. Swallow the medicine with water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking GLUCOSAFE 2.5 and contact your doctor immediately if you experience any of the following side effects:
GLUCOSAFE 2.5 is not recommended for use in pregnancy. Consult your doctor before taking it.
GLUCOSAFE 2.5 is not recommended for use in breastfeeding women as it may pass through the breast milk. Consult your doctor before taking it.
Avoid driving and using machines while taking GLUCOSAFE 2.5 as it may reduce your ability to concentrate or react if your blood sugar is lowered (hypoglycemia).
Avoid drinking alcohol while taking GLUCOSAFE 2.5 as it may increase or decrease the blood sugar levels lowering the action of GLUCOSAFE 2.5.
GLUCOSAFE 2.5 is not recommended for use in patients with severe kidney disease. It should be used with caution in patients with severe kidney disorder. Consult your doctor before taking.
GLUCOSAFE 2.5 is not recommended for use in patients with severe liver disease. It should be used with caution in patients with severe liver disorder. Consult your doctor before taking.
Do not take GLUCOSAFE 2.5 if you are allergic to Glibenclamide.
GLUCOSAFE 2.5 is not recommended for use in patients with coronary artery disease. GLUCOSAFE 2.5 should be used with caution in patients with other heart diseases. Consult your doctor before taking it.
GLUCOSAFE 2.5 is not recommended for use if you:
Before taking GLUCOSAFE 2.5, inform your doctor if you:
Use in pediatrics:
GLUCOSAFE 2.5 is not recommended for use in children and adolescents below 18 years of age. Consult your doctor before taking it.
Use in geriatrics:
GLUCOSAFE 2.5 should be used with caution in elderly patients above 65 years of age as they are sensitive to hypoglycemic action. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition. Consult your doctor before taking GLUCOSAFE 2.5.
A. Drug - Drug interactions:
Before taking GLUCOSAFE 2.5, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally take too much of GLUCOSAFE 2.5, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are characterized by faintness, feeling sick, cold sweats and palpitations.
Drug | : | Glibenclamide |
Pharmacological Category | : | Sulfonylureas |
Therapeutic Indication | : | Type 2 diabetes mellitus |
Dosage Forms | : | Tablet |
How should GLUCOSAFE 2.5 be used in elderly patients?
GLUCOSAFE 2.5 should be used with extra caution in elderly patients above 65 years of age, because they are at high risk of getting low blood sugar (hypoglycemic event).
Can GLUCOSAFE 2.5 cause hair loss?
No, hair loss is not seen with the use of GLUCOSAFE 2.5. However, diabetes can lead to hair loss. Consult your doctor if you have too much hair loss as it could be due to other underlying conditions or a sign of diabetes getting worsened.
Can I stop taking GLUCOSAFE 2.5?
No, GLUCOSAFE 2.5 should not be skipped as it can make your diabetes condition worse. If you miss the dose by mistake, take it when you remember immediately.
Can GLUCOSAFE 2.5 cause weight gain?
Yes, GLUCOSAFE 2.5 can cause weight gain. Closely monitor your diet and exercise regularly. Avoid skipping your meals as it can cause very low blood sugar levels and you may end up taking more sugar.
1. KD Tripathi.Insulin, Oral Antidiabetic Drugs and Glucagon.Essentials of Medical Pharmacology. Eighth Edition. 2019. Page –295.
2. Rajiv Goyal; IshwarlalJialal. Diabetes Mellitus Type 2. [Revised in September 2021] [Accessed on 18th May 2022] https://www.ncbi.nlm.nih.gov/books/NBK513253/
3. Sanofi-aventis. U.S. food and drug administration. [Accessed on 18th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017532s030lbl.pdf
4. TEVA UK Limited. Glibenclamide. [Revised in March 2015] [Accessed on 18th May 2022] https://www.drugs.com/uk/pdf/leaflet/1084495.pdf
5. Chanelle Medical, Loughrea, Co Galwa. Health Products Regulatory Authority (HPRA). [Revised in May 2016] [Accessed on 18th May 2022] https://www.hpra.ie/img/uploaded/swedocuments/2179143.PA0688_040_002.752e1eeb-1045-476a-97ac-9f7549199666.000001Product%20Leaflet%20Approved%205mg.160725.pdf
6. Teva Pharmaceuticals USA, Inc. Glyburide. [Revised on July 2021] [Accessed on 18th May 2022] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50d16f1d-c814-4411-8749-62561321ecce
7. Glibenclamide.MedlinePlus. [Revised on May 2021] [Accessed On 18th May 2022] https://medlineplus.gov/diabetestype2.html
8. Glyburide.MedlinePlus.[Revised in October 2018] [Accessed on 18th May 2022] https://medlineplus.gov/druginfo/meds/a684058.html
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.